Cancer Imaging Systems Market Share, Forecast, Overview and Key...

Cancer Imaging Systems Market Share, Forecast, Overview and Key Companies Analysis by 2028

Veröffentlicht 2021-07-22 05:44:43

1207

The global cancer imaging systems market is projected to be worth USD 12.24 Billion by 2027, according to a current analysis by Emergen Research. The cancer imaging systems market is observing high demand attributed to the increasing incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.

The report provides detailed insights into Cancer Imaging Systems market trends, industry trends, consumer trends, market size, market share, market revenue growth, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2020–2028. The report includes profiles of major players in the Cancer Imaging Systems market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/222

The steady Cancer Imaging Systems market share growth can be attributed to a variety of factors and trends in the global Cancer Imaging Systems market currently. Global Cancer Imaging Systems market revenue growth is supported to a significant extent due to rising focus by major players on product/service expansion into new and untapped domestic markets and rising competition in the market. These factors are expected to drive incline in regional Cancer Imaging Systems market share growth over the forecast period.

Growing technological advancements and increased investments in cancer imaging are causative of the rapid growth of the market. Hologic, Inc., in November 2019, received approval from the US Food and Drug Administration (FDA) for its 3DQuorum™ Imaging Technology, driven by Genius AI™. The technology works simultaneously with Hologic’s Clarity HD™ high-resolution imaging technology and helps radiologists reduce tomosynthesis image volume by 66.0%. The breast imaging system owing to such advancements would produce higher-resolution 3D images, better workflow, and an improved mammography experience for patents necessitating low radiation dose.

In addition, rapidly rising demand and deployment in respective sectors/industries in major and developing countries is supporting growth in terms of Cancer Imaging Systems market share contribution of these countries. In addition, Cancer Imaging Systems market share contribution is expected to continue to incline steadily over the forecast period due to favorable government policies, advancements in technology, and steady economic growth across various regions and countries.

Top key vendors in Cancer Imaging Systems Market include are:

Key participants include GE Healthcare, Hitachi Medical, Becton, Dickinson, and Company, Thermo Fisher Scientific Inc., CR Bard Inc., Agilent Technologies, Abbott, Illumina Inc., Roche, and Philips Healthcare, among others.

Emergen Research has segmented the global cancer imaging systems market on the basis of imaging systems, application, end-users, and region:

Imaging Systems Outlook (Revenue, USD Billion; 2017-2027)
- Mammography
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Ultrasound
- Positron Emission Tomography (PET)
- Others

Application Outlook (Revenue, USD Billion; 2017-2027)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Others

End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals & Clinics
- Diagnostic Centers
- Others

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market

In terms of Cancer Imaging Systems market share and revenue contribution to the global Cancer Imaging Systems market, North America is expected to maintain its dominance over other regional markets over the forecast period. Presence of major companies in countries in the region is a key factor supporting rapid increase in Cancer Imaging Systems market share.

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Cancer Imaging Systems Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2020 - 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Region wise performance of the Cancer Imaging Systems industry

Asia Pacific market share contribution to the global Cancer Imaging Systems market is expected to continue to register comparatively faster growth rate than other regional markets between 2020 and 2028. Rapid growth rate of China and India Cancer Imaging Systems market share contribution can be attributed to increasing population and disposable income, and steady economic growth, and the trend is expected to continue going ahead.

Steady increase in Europe Cancer Imaging Systems market share growth is primarily supported by continuous developments in major countries in the region. Robust focus on research and development initiatives by major firms in countries in the region is also expected to continue to support market share growth of the Europe Cancer Imaging Systems market going ahead.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

We can customize our reports for our customers, for instance, we can add or remove manufacturers, applications or product types, whatever you need in the report. Ask for it by contacting us@ https://www.emergenresearch.com/request-for-customization/222

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Cancer Imaging Systems industry for the forecast period 2020-2027?
What are the major driving forces expected to impact the development of the Cancer Imaging Systems market across different regions?
Who are the major driving forces expected to decide the fate of the Cancer Imaging Systems industry worldwide?
Who are the prominent market players making a mark in the Cancer Imaging Systems market with their winning strategies?
Which Cancer Imaging Systems industry trends are likely to shape the future of the industry during the forecast period 2020-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Cancer Imaging Systems market?

Table of Content

Chapter 1. Methodology & Sources

1.1. Cancer Imaging Systems Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Cancer Imaging Systems Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2021-2028